1,369 results on '"Mann, Graham"'
Search Results
52. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families
53. Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center
54. The association of dermatologist demographic density with melanoma survival in New South Wales, Australia
55. Perspectives of health professionals and patients on implementation of a predictive model of response to immunotherapies in advanced melanoma
56. Spatial and Temporal Variations in Aerosol Properties in High-Resolution Convection-Permitting Simulations in an Idealized Tropical Marine Domain
57. Global atmospheric particle formation from CERN CLOUD measurements
58. Evaluation of Linkage of Breast Cancer to the Putative BRCA3 Locus on Chromosome 13q21 in 128 Multiple Case Families from the Breast Cancer Linkage Consortium
59. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas
60. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity
61. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
62. The 2019 Raikoke eruption as a testbed for rapid assessment of volcanic atmospheric impacts by the Volcano Response group
63. Molecular Epidemiology of Melanoma
64. Standardized Field Testing of Assistant Robots in a Mars-Like Environment
65. Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis
66. A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in Australia
67. Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia
68. An assigned responsibility system for robotic teleoperation control
69. Data from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
70. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
71. Supplementary Figure Legends from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
72. Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
73. Supplementary Figures and Tables from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
74. Data from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
75. Supplementary Table 1 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
76. Supplementary Table 2 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
77. Data from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
78. Supplement 1 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
79. Data from Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
80. Supplementary Table 3 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
81. Supplementary Data from Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
82. Supplement 3 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
83. Supplementary Table 4 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma
84. Supplement 5 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
85. Supplement 2 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
86. Supplement 4 from Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
87. Data from Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults
88. Supplementary Figure Legend from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
89. Figure S5 from PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma
90. Supplementary materials (clean version) from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
91. Supplementary Figure S1 from Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults
92. Supplementary Table 2 from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
93. Supplementary Data from Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma
94. Supplementary Table S1 from Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults
95. Personalised risk booklet - an example from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
96. Table S1 from PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma
97. Supplementary Figure 1 from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
98. Supplementary Tables 1, 3 and 4 from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
99. Supplementary Figure S3 from UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas
100. Supplementary Methods and References from UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.